Combination of Detoxified Pneumolysin Derivative ΔA146Ply and Berbamine as a Treatment Approach for Breast Cancer

Harbeck, 2017, Breast cancer, Lancet, 389, 1134, 10.1016/S0140-6736(16)31891-8 Torre, 2015, Global cancer statistics, 2012, CA Cancer J. Clin., 65, 87, 10.3322/caac.21262 Chen, 2016, Cancer statistics in China, 2015, CA Cancer J. Clin., 66, 115, 10.3322/caac.21338 Huang, 2015, Epithelial-mesenchymal transition and drug resistance in breast cancer (Review), Int. J. Oncol., 47, 840, 10.3892/ijo.2015.3084 Tang, 2016, Classification, Treatment Strategy, and Associated Drug Resistance in Breast Cancer, Clin. Breast Cancer, 16, 335, 10.1016/j.clbc.2016.05.012 The, 2018, Cancer drugs in China: affordability and creativity, Lancet, 391, 1866, 10.1016/S0140-6736(18)31034-1 Granier, 2016, [Cancer immunotherapy: Rational and recent breakthroughs], Rev. Med. Interne, 37, 694, 10.1016/j.revmed.2016.05.023 Hassan, 2016, New Life for Immunotoxin Cancer Therapy, Clin. Cancer Res., 22, 1055, 10.1158/1078-0432.CCR-15-1623 Shen, 2016, Immunovirotherapy with vesicular stomatitis virus and PD-L1 blockade enhances therapeutic outcome in murine acute myeloid leukemia, Blood, 127, 1449, 10.1182/blood-2015-06-652503 Alvey, 2017, SIRPA-Inhibited, Marrow-Derived Macrophages Engorge, Accumulate, and Differentiate in Antibody-Targeted Regression of Solid Tumors, Curr. Biol., 27, 2065, 10.1016/j.cub.2017.06.005 Gholamin, 2017, Disrupting the CD47-SIRPα anti-phagocytic axis by a humanized anti-CD47 antibody is an efficacious treatment for malignant pediatric brain tumors, Sci. Transl. Med., 9, eaaf2968, 10.1126/scitranslmed.aaf2968 Melero, 2017, Cancer immunotherapy full speed ahead, Ann. Oncol., 28, xii1, 10.1093/annonc/mdx739 Diken, 2018, Translating Science into Survival: Report on the Third International Cancer Immunotherapy Conference, Cancer Immunol. Res., 6, 10, 10.1158/2326-6066.CIR-17-0656 Lee, 2019, Cellular immunotherapy for acute myeloid leukemia: How specific should it be?, Blood Rev., 35, 18, 10.1016/j.blre.2019.02.001 Haslam, 2019, Estimation of the Percentage of US Patients With Cancer Who Are Eligible for and Respond to Checkpoint Inhibitor Immunotherapy Drugs, JAMA Netw. Open, 2, e192535, 10.1001/jamanetworkopen.2019.2535 Tanoue, 2019, A defined commensal consortium elicits CD8 T cells and anti-cancer immunity, Nature, 565, 600, 10.1038/s41586-019-0878-z Skelly, 2019, Mining the microbiota for microbial and metabolite-based immunotherapies, Nat. Rev. Immunol., 19, 305, 10.1038/s41577-019-0144-5 Helmink, 2019, The microbiome, cancer, and cancer therapy, Nat. Med., 25, 377, 10.1038/s41591-019-0377-7 Zeng, 2019, Directing toll-like receptor signaling in macrophages to enhance tumor immunotherapy, Curr. Opin. Biotechnol., 60, 138, 10.1016/j.copbio.2019.01.010 Chowdhury, 2019, Programmable bacteria induce durable tumor regression and systemic antitumor immunity, Nat. Med., 25, 1057, 10.1038/s41591-019-0498-z Gopalakrishnan, 2018, The Influence of the Gut Microbiome on Cancer, Immunity, and Cancer Immunotherapy, Cancer Cell, 33, 570, 10.1016/j.ccell.2018.03.015 Zitvogel, 2017, Anticancer effects of the microbiome and its products, Nat. Rev. Microbiol., 15, 465, 10.1038/nrmicro.2017.44 Roy, 2017, Microbiota: a key orchestrator of cancer therapy, Nat. Rev. Cancer, 17, 271, 10.1038/nrc.2017.13 Zitvogel, 2016, Microbiome and Anticancer Immunosurveillance, Cell, 165, 276, 10.1016/j.cell.2016.03.001 Feng, 2019, A toll-like receptor agonist mimicking microbial signal to generate tumor-suppressive macrophages, Nat. Commun., 10, 2272, 10.1038/s41467-019-10354-2 Kirkham, 2006, Construction and immunological characterization of a novel nontoxic protective pneumolysin mutant for use in future pneumococcal vaccines, Infect. Immun., 74, 586, 10.1128/IAI.74.1.586-593.2006 Liu, 2014, Mucosal immunization with recombinant fusion protein DnaJ-ΔA146Ply enhances cross-protective immunity against Streptococcus pneumoniae infection in mice via interleukin 17A, Infect. Immun., 82, 1666, 10.1128/IAI.01391-13 Su, 2017, Subcutaneous Immunization with Fusion Protein DnaJ-ΔA146Ply without Additional Adjuvants Induces both Humoral and Cellular Immunity against Pneumococcal Infection Partially Depending on TLR4, Front. Immunol., 8, 686, 10.3389/fimmu.2017.00686 Wu, 2018, Engineering detoxified pneumococcal pneumolysin derivative ΔA146PLY for self-biomineralization of calcium phosphate: Assessment of their protective efficacy in murine infection models, Biomaterials, 155, 152, 10.1016/j.biomaterials.2017.11.018 Fu, 2018, A novel autophagy inhibitor berbamine blocks SNARE-mediated autophagosome-lysosome fusion through upregulation of BNIP3, Cell Death Dis., 9, 243, 10.1038/s41419-018-0276-8 Zheng, 2017, Berbamine postconditioning protects the heart from ischemia/reperfusion injury through modulation of autophagy, Cell Death Dis., 8, e2577, 10.1038/cddis.2017.7 Wang, 2009, Suppression of growth, migration and invasion of highly-metastatic human breast cancer cells by berbamine and its molecular mechanisms of action, Mol. Cancer, 8, 81, 10.1186/1476-4598-8-81 Zhang, 2017, Chloroquine (CQ) exerts anti-breast cancer through modulating microenvironment and inducing apoptosis, Int. Immunopharmacol., 42, 100, 10.1016/j.intimp.2016.11.027 Bianchini, 2016, Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease, Nat. Rev. Clin. Oncol., 13, 674, 10.1038/nrclinonc.2016.66 Nauts, 1946, The treatment of malignant tumors by bacterial toxins as developed by the late William B. Coley, M.D., reviewed in the light of modern research, Cancer Res., 6, 205 Kiselyov, 2015, Treatment of non-muscle invasive bladder cancer with Bacillus Calmette-Guerin (BCG): Biological markers and simulation studies, BBA Clin., 4, 27, 10.1016/j.bbacli.2015.06.002 Greig, 2015, Brexpiprazole: First Global Approval, Drugs, 75, 1687, 10.1007/s40265-015-0462-2 Esener, 2018, Donkey milk kefir induces apoptosis and suppresses proliferation of Ehrlich ascites carcinoma by decreasing iNOS in mice, Biotech. Histochem., 93, 424, 10.1080/10520295.2018.1448112 Zhao, 2018, Liraglutide inhibits the proliferation and promotes the apoptosis of MCF-7 human breast cancer cells through downregulation of microRNA-27a expression, Mol. Med. Rep., 17, 5202 Wang, 2018, miR-199a-5p inhibits proliferation and induces apoptosis in hemangioma cells through targeting HIF1A, Int. J. Immunopathol. Pharmacol., 31, 10.1177/0394632017749357 Rahmani, 2018, Cotargeting BCL-2 and PI3K Induces BAX-Dependent Mitochondrial Apoptosis in AML Cells, Cancer Res., 78, 3075, 10.1158/0008-5472.CAN-17-3024 Karki, 2017, Inflammasomes and Cancer, Cancer Immunol. Res., 5, 94, 10.1158/2326-6066.CIR-16-0269 Hu, 2017, Polymeric Nanoparticles Induce NLRP3 Inflammasome Activation and Promote Breast Cancer Metastasis, Macromol. Biosci., 17, 1700273, 10.1002/mabi.201700273 Ershaid, 2019, NLRP3 inflammasome in fibroblasts links tissue damage with inflammation in breast cancer progression and metastasis, Nat. Commun., 10, 4375, 10.1038/s41467-019-12370-8 Weichand, 2017, S1PR1 on tumor-associated macrophages promotes lymphangiogenesis and metastasis via NLRP3/IL-1β, J. Exp. Med., 214, 2695, 10.1084/jem.20160392 Littmann, 2009, Streptococcus pneumoniae evades human dendritic cell surveillance by pneumolysin expression, EMBO Mol. Med., 1, 211, 10.1002/emmm.200900025 Zhang, 2018, Berbamine suppresses cell viability and induces apoptosis in colorectal cancer via activating p53-dependent apoptotic signaling pathway, Cytotechnology, 70, 321, 10.1007/s10616-017-0146-8 Zhang, 2018, Berbamine suppresses cell proliferation and promotes apoptosis in ovarian cancer partially via the inhibition of Wnt/β-catenin signaling, Acta Biochim. Biophys. Sin. (Shanghai), 50, 532, 10.1093/abbs/gmy036 Zhao, 2016, Berbamine inhibited the growth of prostate cancer cells in vivo and in vitro via triggering intrinsic pathway of apoptosis, Prostate Cancer Prostatic Dis., 19, 358, 10.1038/pcan.2016.29 Wang, 2009, Berbamine induces Fas-mediated apoptosis in human hepatocellular carcinoma HepG2 cells and inhibits its tumor growth in nude mice, J. Asian Nat. Prod. Res., 11, 219, 10.1080/10286020802675076 Wei, 2009, Berbamine exhibits potent antitumor effects on imatinib-resistant CML cells in vitro and in vivo, Acta Pharmacol. Sin., 30, 451, 10.1038/aps.2009.19 Handgretinger, 2018, The potential role of γδ T cells after allogeneic HCT for leukemia, Blood, 131, 1063, 10.1182/blood-2017-08-752162 Silva-Santos, 2015, γδ T cells in cancer, Nat. Rev. Immunol., 15, 683, 10.1038/nri3904 Zou, 2017, γδ T cells in cancer immunotherapy, Oncotarget, 8, 8900, 10.18632/oncotarget.13051 Silva-Santos, 2019, γδT cells: pleiotropic immune effectors with therapeutic potential in cancer, Nat. Rev. Cancer, 19, 392, 10.1038/s41568-019-0153-5 Hodgins, 2017, Nano-technology based carriers for nitrogen-containing bisphosphonates delivery as sensitisers of γδ T cells for anticancer immunotherapy, Adv. Drug Deliv. Rev., 114, 143, 10.1016/j.addr.2017.07.003 Havran, 2018, Specialized Antitumor Functions for Skin γδ T Cells, J. Immunol., 200, 3029, 10.4049/jimmunol.1800356 Tanaka, 1995, Natural and synthetic non-peptide antigens recognized by human gamma delta T cells, Nature, 375, 155, 10.1038/375155a0 Agarwal, 2013, Streptococcus pneumoniae endopeptidase O (PepO) is a multifunctional plasminogen- and fibronectin-binding protein, facilitating evasion of innate immunity and invasion of host cells, J. Biol. Chem., 288, 6849, 10.1074/jbc.M112.405530